---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-245663"
form_type: "8-K"
ticker: "GOCO"
cik: "0001808220"
company_name: "GoHealth, Inc."
filed_at: "2022-09-15T23:59:59+00:00"
generated_at: "2026-06-23T09:28:21.892920+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# GoHealth director Tawil resigns; Christopher Litchford appointed as Centerbridge designee

## Summary
- Tawil resigned as Centerbridge director on Sept 11, 2022; no disagreement with GoHealth.
- Christopher Litchford, Managing Director at Centerbridge, appointed to Board on Sept 14, 2022.
- Litchford will serve as Class II director with term expiring at the 2025 annual meeting.
- Litchford receives no additional compensation for board service; standard indemnification executed.
- No reportable related-party transactions between Litchford and GoHealth beyond Centerbridge matters.

## SEC filing metadata
- accession: 0001193125-22-245663
- form_type: 8-K
- ticker: GOCO
- cik: 0001808220
- company_name: GoHealth, Inc.
- filed_at: 2022-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/0001193125-22-245663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/d256310d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-245663
- JSON: https://secwatch.observer/filing/0001193125-22-245663.json
- Plain text: https://secwatch.observer/filing/0001193125-22-245663.txt

## Key facts
- Executive change
  Christopher Litchford was appointed as Director at GoHealth, Inc..
  - Action: appointed
  - Role: Director
  source text: Mr. Litchford was appointed as a director by the Board of the Company on September 14, 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/0001193125-22-245663-index.htm
- Executive change
  Ms. Tawil resigned as Director at GoHealth, Inc..
  - Action: resigned
  - Role: Director
  source text: On September 11, 2022, Ms. Tawil resigned from the Board of the Company as a Centerbridge Director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808220/000119312522245663/0001193125-22-245663-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.